Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 4:01 pm Unchanged | 2024-01-22 | 13D | OPKO HEALTH, INC OPK | Phillip Frost, M.D. | 244,703,683 35.000% | 0 (Unchanged) | Filing History |
| 2024-01-22 4:26 pm Sale | 2024-01-18 | 13D | OPKO HEALTH, INC OPK | Phillip Frost, M.D. | 244,703,683 33.900% | -7,723,710 (-3.06%) | Filing History |
| 2023-09-28 4:22 pm Purchase | 2023-09-19 | 13G | VERU INC VERU | Phillip Frost, M.D. | 510,025 5.700% | 10,000 (+2.00%) | Filing History |
| 2023-09-25 4:34 pm Purchase | 2023-09-19 | 13D | FLUENT INC FLNT | Phillip Frost, M.D. | 3,147,479 23.300% | 16,667 (+0.53%) | Filing History |
| 2023-09-15 4:59 pm Purchase | 2023-09-11 | 13D | NOCOPI TECHNOLOGIES INC MD COM NNUP | Phillip Frost, M.D. | 1,250,000 11.900% | 1,250,000 (New Position) | Filing History |
| 2023-04-19 4:17 pm Purchase | 2023-02-23 | 13G | COMSOVEREIGN HLDG CORP COM PAR COMS | Phillip Frost, M.D. | 45,618 1.700% | 2 (+0.00%) | Filing History |
| 2023-04-19 4:16 pm Purchase | 2023-04-12 | 13G | VERU INC VERU | Phillip Frost, M.D. | 500,025 6.100% | 500,025 (New Position) | Filing History |
| 2023-04-14 5:16 pm Purchase | 2023-04-11 | 13D | NEXTPLAT CORP NXPL | Phillip Frost, M.D. | 34,286 23.700% | 34,286 (New Position) | Filing History |
| 2023-04-14 4:01 pm Purchase | 2023-04-04 | 13D | COCRYSTAL PHARMA INC PAR $ COCP | Phillip Frost, M.D. | 1,332,608 13.100% | 1,022,082 (+329.15%) | Filing History |
| 2023-02-21 4:20 pm Purchase | 2023-02-10 | 13D | OPKO HEALTH, INC OPK | Phillip Frost, M.D. | 252,427,393 31.900% | 11,835,241 (+4.92%) | Filing History |
| 2023-02-03 5:22 pm Purchase | 2023-01-01 | 13G | DOUGLAS ELLIMAN INC /O DI DOUG | Phillip Frost, M.D. | 7,550,619 8.900% | 67,538 (+0.90%) | Filing History |
| 2023-02-03 5:13 pm Sale | 2023-01-01 | 13G | PEAK BIO INC PKBO | Phillip Frost, M.D. | 315,000 1.600% | -135,000 (-30.00%) | Filing History |
| 2022-08-19 4:05 pm Purchase | 2022-06-24 | 13D | OPKO HEALTH, INC OPK | Phillip Frost, M.D. | 240,592,152 30.900% | 10,868,689 (+4.73%) | Filing History |
| 2022-02-11 3:32 pm Purchase | 2021-12-31 | 13G | DOUGLAS ELLIMAN INC /O DI DOUG | Phillip Frost, M.D. | 7,483,081 9.200% | 7,483,081 (New Position) | Filing History |